Genetic Counseling's Evolution: A Conversation with Carrie Haverty, MS, CGC
The field of genetic counseling is transforming, and Carrie Haverty is at the forefront of this exciting journey. As a distinguished genetic counselor and the NSGC president-elect, Haverty offers a unique perspective on the profession's growth, the impact of gene therapy, and the importance of multidisciplinary healthcare.
Haverty's journey began with a master's degree in genetic counseling from the University of California Irvine, followed by a focus on high-risk prenatal care and access to diagnostic technologies. Her expertise led her to Mirvie, where she is currently developing the RNA platform. Haverty's clinical experience has been instrumental in product development at various companies, including Counsyl, Myriad, and Miroculus.
But here's where it gets controversial... Haverty's leadership extends beyond the lab. She served on the NSGC board and was elected president for 2026, succeeding Sara Pirzadeh-Miller. At the 44th NSGC Annual Conference, she addressed attendees, sharing her leadership path, the opportunities and challenges for genetic counselors, and her vision for the organization.
During an exclusive interview with NeurologyLive®, Haverty discussed the expanding role of genetic counselors in various specialties, emphasizing patient-centric care. She highlighted the field's challenges, including patient reimbursement and healthcare navigation. And this is the part most people miss... Haverty passionately believes in the potential of genetic counseling, especially with the integration of genetic counselors into multidisciplinary teams.
NeurologyLive: What were the standout moments at the conference?
Carrie Haverty: The conference was thrilling, especially the professional issues panel. We had trailblazing genetic counselors sharing their innovative work, which is invaluable for the profession. The expansion of genetic counselors into new specialties is fascinating, like supporting patients near the end of life and helping families through the process.
What excites you about genetic counseling's future?
The increasing involvement of targeted therapeutics and biopharma in genetic testing is a game-changer. Genetic counselors are crucial in informing families about treatment options and developing diagnostic tools for precise therapies. This extends beyond oncology to cardiology, rare pediatric diseases, and more. Gene therapy is an integral part of this evolution.
How is gene therapy evolving?
Gene therapy has transformed from science fiction to reality. Understanding the genetic testing and molecular aspects of conditions is vital, but so is grasping the benefits and risks. Genetic counselors are uniquely positioned to enroll patients in trials and identify eligible individuals, leading to therapy development. They ensure patients and families understand the implications of therapies, enabling informed consent.
What's happening in neurology that's noteworthy?
Neurology is buzzing with Alzheimer's research, and for good reason. New treatments are on the horizon, and we're expanding beyond early-onset cases. We're considering various testing and identification points, preventive care, and therapies. The conference had a late-breaking session on autism, advocating for patients in a complex environment, where genetic counselors' voices are essential.
What's on the horizon for genetic counseling?
The field's rapid growth and change are exciting. Integrating new technologies into patient-centered care across specialties is a key focus. Haverty envisions genetic counselors in intensive care, primary care, cardiology, infectious diseases, and more, in addition to their established roles. The goal is to expand genetic testing, counseling, and therapies across the healthcare ecosystem, turning lab ideas into real precision medicine.
What are the field's biggest hurdles?
Reimbursement is a significant challenge. Genetic counselors aren't recognized by CMS as healthcare providers, limiting independent billing. They're working towards legislative change to gain recognition and improve efficiency for Medicare beneficiaries. A new CPT code for genetic counseling, 96041, is a step forward, but implementation takes time.
Are there overlooked aspects of genetic counseling?
Postmortem genetic testing is an emerging area. Genetic counselors are finding ways to be involved in autopsy processes to identify causes of death and inform families. It's a fascinating development, with dedicated sessions at the conference.
Any final thoughts?
The growing interest from clinicians in integrating genetic counselors into multidisciplinary teams is encouraging. Haverty emphasizes the importance of this approach in modern clinical care. She hopes to see more genetic counselors in specialty clinics, ensuring a comprehensive and patient-centric healthcare experience.
Transcript edited for clarity. For more NSGC coverage, click here.
